Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES Trial

NCT03568890 is registered in ClinicalTrials.gov with Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec as lead sponsor.

NCT NCT03568890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03568890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES Trial
Lead sponsor
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 1, 2018
Completion date
September 1, 2030
Enrollment
510 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, left atrial appendage closure, stroke, thrombosis, tia